[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
September 28, 1912


Author Affiliations

Secretary of the Committee WASHINGTON, D. C.

JAMA. 1912;LIX(13):1163-1166. doi:10.1001/jama.1912.04270090407008

The Council on Pharmacy and Chemistry of the American Medical Association has been repeatedly though erroneously criticized for being destructive rather than constructive in its work, and not a few medical practitioners have pointed out the difficulty of consistently following the efforts that are being made to improve on the conditions now existing in relation to the use of drugs as aids in the prevention or the treatment of disease.

The difficulties that would be encountered by a physician in active practice in any attempt to differentiate between useful and useless articles will suggest themselves to any one who will take the time to look over one or more of the current price-lists of drugs and proprietary medicines. The many thousands of meaningless names found in such a list are disconcerting to even the best-informed medical practitioner, and to one who can give only a limited amount of time and

First Page Preview View Large
First page PDF preview
First page PDF preview